Nath Bio-Genes (India) Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Nath Bio-Genes (India) Ltd. on BSE

Search Inside the pdf :

Nath Bio-Genes (India) Ltd.

22 Aug 2025

170.83

-1.21%

AGM

Nath Bio-Genes (India) Ltd - 537291 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report

BSE India

32nd Annual General Meeting of Nath Bio-Genes (India) Limited held today on 22nd August 2025, Pursuant to Regulation 30 and Regulation 44. Please find the following. 1. Proceedings of Annual General Meeting. 2. Voting Results. 3. Scrutinizers Report.

pdf

Nath Bio-Genes (India) Ltd.

31 Jul 2025

170.83

-1.21%

Corp. Note

Nath Bio-Genes (India) Ltd - 537291 - Reg. 34 (1) Annual Report.

BSE India

Annual Report for the year 2024-25

pdf

Nath Bio-Genes (India) Ltd.

31 Jul 2025

170.83

-1.21%

Corp. Action

Nath Bio-Genes (India) Ltd - 537291 - Thursday 14Th August 2025

BSE India

Record date for the purpose of Annual General Meeting.

pdf

Nath Bio-Genes (India) Ltd.

31 Jul 2025

170.83

-1.21%

AGM

Nath Bio-Genes (India) Ltd - 537291 - Friday 22Nd August 2025

BSE India

Notice of 32nd Annual General Meeting.

pdf

Nath Bio-Genes (India) Ltd.

16 Jul 2025

170.83

-1.21%

Company Update

Nath Bio-Genes (India) Ltd - 537291 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, …

BSE India

Compliance Certificate under Reg 74(5) of SEBI_ DP Regulation

pdf

Nath Bio-Genes (India) Ltd.

11 Jul 2025

170.83

-1.21%

Investor Presentation

Nath Bio-Genes (India) Ltd - 537291 - Announcement under Regulation 30 (LODR)-Investor Presentation

BSE India

Investor Presentation on financial results as on 30th June 2025

pdf

Nath Bio-Genes (India) Ltd.

11 Jul 2025

170.83

-1.21%

Result

Nath Bio-Genes (India) Ltd - 537291 - Unaudited Financial Results As On 30Th June 2025.

BSE India

The Board of Directors of the Company at Meeting held today on 11th July 2025 has approved the following, 1. Stanaldone and Consolidated Financial Results as on 30th June 2025. 2. Appointment of Ms. Payal Jain as Additional Director (Independent) of the Company.

pdf

	Jun 2025	Mar 2025	Jun 2024	Change QoQ%	Change YoY%
Total Revenue Qtr	285.46	55.83	244.01	411.3%	17.0%
Operating Profit Qtr	38.28	0.41	36.54	9236.6%	4.8%
Net Profit Qtr	37.28	1.48	33.35	2418.9%	11.8%
Earning Per Share Adjusted latest Qtr	19.62	0.78	17.55	2415.4%	11.8%

* Consolidated data

Detailed Results

Nath Bio-Genes (India) Ltd.

04 Jul 2025

170.83

-1.21%

Board Meeting

Nath Bio-Genes (India) Ltd - 537291 - Board Meeting Intimation for Approval Of Unaudited Financial Results …

BSE India

Nath Bio-Genes (India) Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/07/2025 ,inter alia, to consider and approve unaudited financial results as on 30th June 2025.

pdf